Knowledge and Carotenoid Intake in Early-Stage Age-Related Macular Degeneration Patients: A Cross-Sectional Study
European Journal of Clinical Pharmacy · 30.12.2025 · 7 (1) · 9604-9612
DOI: 10.61336/ejcp/25-08-703 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 30.12.2025.
Abstract (Originalsprache)
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss among older adults worldwide. Carotenoids, particularly lutein and zeaxanthin, play a protective role in maintaining macular health through antioxidant mechanisms and blue-light filtration. However, patient awareness regarding nutritional interventions remains poorly documented in developing countries.
Objective
To assess knowledge levels and dietary intake of carotenoids among patients with early-stage AMD and to evaluate the role of healthcare providers in nutritional counselling.
Methods
A cross-sectional study was conducted at LRBT Secondary Eye Hospital, Rahim Yar Khan, Pakistan, from January to April 2026. Fifty patients aged ≥50 years with early-stage (dry) AMD were enrolled using convenience sampling. Data were collected through a structured questionnaire assessing disease awareness, carotenoid knowledge, dietary habits, and barriers to supplementation. Descriptive statistics and chi-square analysis were performed using SPSS version 27.0.1.
Results
Among 50 participants (68% from rural areas), only 18% were aware that diet influences AMD progression. Only 24% recalled their consultant mentioning lutein or zeaxanthin. Regarding dietary intake, 58% consumed leafy vegetables twice weekly and 58% consumed orange/yellow vegetables once weekly. Lack of awareness (84%) was the primary barrier to supplementation, while 44% considered supplements a financial burden. Knowledge scores ranged from 7-11 (maximum possible 15), with 30% achieving a score of 9.
Conclusion
Significant gaps exist between potential benefits of carotenoids and actual patient knowledge and consumption. Structured nutritional counselling should be integrated into routine ophthalmic care for AMD patients.
Zitieren
APA
(2025). Knowledge and Carotenoid Intake in Early-Stage Age-Related Macular Degeneration Patients: A Cross-Sectional Study. European Journal of Clinical Pharmacy, 7(1), 9604-9612. https://doi.org/10.61336/ejcp/25-08-703
Vancouver
Knowledge and Carotenoid Intake in Early-Stage Age-Related Macular Degeneration Patients: A Cross-Sectional Study. European Journal of Clinical Pharmacy. 2025;7(1):9604-9612. doi:10.61336/ejcp/25-08-703
BibTeX
@article{euvimed2025,
title = {Knowledge and Carotenoid Intake in Early-Stage Age-Related Macular Degeneration Patients: A Cross-Sectional Study},
journal = {European Journal of Clinical Pharmacy},
year = {2025},
volume = {7},
number = {1},
pages = {9604--9612},
doi = {10.61336/ejcp/25-08-703}
}
EUVIMED